Published in JAMA Neurol on July 01, 2013
Design and validation of a periodic leg movement detector. PLoS One (2014) 1.52
Narcolepsy and predictors of positive MSLTs in the Wisconsin Sleep Cohort. Sleep (2014) 1.04
Challenges in diagnosing narcolepsy without cataplexy: a consensus statement. Sleep (2014) 1.00
History of narcolepsy at Stanford University. Immunol Res (2014) 0.83
Usefulness of a Nocturnal SOREMP for Diagnosing Narcolepsy with Cataplexy in a Pediatric Population. Sleep (2015) 0.83
Nocturnal Sleep Dynamics Identify Narcolepsy Type 1. Sleep (2015) 0.81
Central Disorders of Hypersomnolence: Focus on the Narcolepsies and Idiopathic Hypersomnia. Chest (2015) 0.78
Sleep dynamics beyond traditional sleep macrostructure. Sleep (2013) 0.76
SMART DOCS: a new patient-centered outcomes and coordinated-care management approach for the future practice of sleep medicine. Sleep (2015) 0.75
Altered Sleep Stage Transitions of REM Sleep: A Novel and Stable Biomarker of Narcolepsy. J Clin Sleep Med (2015) 0.75
Prevalence and Clinical Correlates of a Short Onset REM Period (SOREMP) during Routine PSG. Sleep (2015) 0.75
How Can We Better Leverage the Nocturnal Polysomnogram in the Diagnosis of Childhood-Onset Narcolepsy? Sleep (2015) 0.75
Meta-analysis of quantitative sleep parameters from childhood to old age in healthy individuals: developing normative sleep values across the human lifespan. Sleep (2004) 10.08
Hypocretin (orexin) deficiency in human narcolepsy. Lancet (2000) 7.92
Practice parameters for the indications for polysomnography and related procedures: an update for 2005. Sleep (2005) 6.64
Guidelines for the multiple sleep latency test (MSLT): a standard measure of sleepiness. Sleep (1986) 6.04
Practice parameters for clinical use of the multiple sleep latency test and the maintenance of wakefulness test. Sleep (2005) 5.66
The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol (2002) 4.03
Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups. Am J Hum Genet (2001) 3.51
Narcolepsy is strongly associated with the T-cell receptor alpha locus. Nat Genet (2009) 3.33
HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients. Sleep (1997) 2.59
Correlates of sleep-onset REM periods during the Multiple Sleep Latency Test in community adults. Brain (2006) 2.35
The clinical use of the MSLT and MWT. Sleep (2005) 2.14
Validation of a cataplexy questionnaire in 983 sleep-disorders patients. Sleep (1999) 1.76
NOCTURNAL SLEEP OF NARCOLEPTICS. Electroencephalogr Clin Neurophysiol (1963) 1.46
Nocturnal REM latency and sleep disturbance in narcolepsy. Sleep (1984) 1.44
First-night effect in normal subjects and psychiatric inpatients. Sleep (1995) 1.34
Value of the multiple sleep latency test (MSLT) for the diagnosis of narcolepsy. Sleep (1997) 1.33
From wakefulness to excessive sleepiness: what we know and still need to know. Sleep Med Rev (2008) 1.29
Predictors of hypocretin (orexin) deficiency in narcolepsy without cataplexy. Sleep (2012) 1.28
Symptomatic narcolepsy in patients with neuromyelitis optica and multiple sclerosis: new neurochemical and immunological implications. Arch Neurol (2009) 1.27
The 10-year risk of verified motor vehicle crashes in relation to physiologic sleepiness. Sleep (2010) 1.25
CSF hypocretin-1 assessment in sleep and neurological disorders. Lancet Neurol (2008) 1.24
The prevalence of multiple sleep-onset REM periods in a population-based sample. Sleep (2006) 1.17
Studies in psychophysiology of dreams. III. The dream of narcolepsy. Arch Gen Psychiatry (1960) 1.12
Sleep onset REM periods during multiple sleep latency tests in patients evaluated for sleep apnea. Am J Respir Crit Care Med (2000) 1.03
Rationale, design and findings from the Wisconsin Sleep Cohort Study: Toward understanding the total societal burden of sleep disordered breathing. Sleep Med Clin (2009) 1.02
The reliability of the diagnostic features in patients with narcolepsy. Biol Psychiatry (1996) 1.01
Multiple sleep latency measures in narcolepsy and behaviourally induced insufficient sleep syndrome. Sleep Med (2009) 1.01
Effect of age on MSLT results in patients with narcolepsy-cataplexy. Neurology (2004) 1.00
Daytime testing after laboratory or home-based polysomnography: comparisons of middle-aged insomnia sufferers and normal sleepers. J Sleep Res (2003) 0.98
Obstructive sleep apnea in narcolepsy. Sleep Med (2009) 0.95
English translations of the first clinical reports on narcolepsy and cataplexy by Westphal and Gélineau in the late 19th century, with commentary. J Clin Sleep Med (2007) 0.95
HLA and hypocretin studies in Korean patients with narcolepsy. Sleep (2002) 0.89
Hypocretin (orexin) deficiency predicts severe objective excessive daytime sleepiness in narcolepsy with cataplexy. J Neurol Neurosurg Psychiatry (2006) 0.87
Interrater and intrarater reliability in multiple sleep latency test. J Clin Neurophysiol (2008) 0.87
Reduction of REM sleep latency associated with HLA-DQB1*0602 in normal adults. Lancet (1998) 0.86
Scoring reliability of the multiple sleep latency test in a clinical population. Sleep (2000) 0.86
Relationship between clinical characteristics of narcolepsy and CSF orexin-A levels. J Sleep Res (2011) 0.85
Psychometric evaluation of daytime sleepiness and nocturnal sleep onset scales in a representative community sample. Biol Psychiatry (1999) 0.82
Sleep- and circadian-dependent modulation of REM density. J Sleep Res (2002) 0.80
Juvenile onset narcolepsy in an individual with Turner syndrome. A case report. Sleep (1991) 0.79
Effects of sleep interruption on REM-NREM cycle in nocturnal human sleep. Electroencephalogr Clin Neurophysiol (1989) 0.78
Sleep onset REM period appearance rate is affected by REM propensity in circadian rhythm in normal nocturnal sleep. Clin Neurophysiol (2000) 0.78
Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med (2002) 14.26
Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index. PLoS Med (2004) 11.17
Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin sleep cohort. Sleep (2008) 8.69
An open letter to The BMJ editors on qualitative research. BMJ (2016) 7.49
Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol (2013) 7.31
Narcolepsy with cataplexy. Lancet (2007) 4.81
Excess weight and sleep-disordered breathing. J Appl Physiol (1985) (2005) 4.72
History of the development of sleep medicine in the United States. J Clin Sleep Med (2005) 4.22
Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China. Ann Neurol (2011) 4.09
Sleep-disordered breathing and cancer mortality: results from the Wisconsin Sleep Cohort Study. Am J Respir Crit Care Med (2012) 3.83
Shift work sleep disorder: prevalence and consequences beyond that of symptomatic day workers. Sleep (2004) 3.78
Risk factors for obstructive sleep apnea in adults. JAMA (2004) 3.73
Association of sleep-disordered breathing and the occurrence of stroke. Am J Respir Crit Care Med (2005) 3.73
Association of sleep apnea and type II diabetes: a population-based study. Am J Respir Crit Care Med (2005) 3.42
Narcolepsy is strongly associated with the T-cell receptor alpha locus. Nat Genet (2009) 3.33
Post-H1N1 narcolepsy-cataplexy. Sleep (2010) 3.10
Elevated anti-streptococcal antibodies in patients with recent narcolepsy onset. Sleep (2009) 3.06
Kleine-Levin syndrome: a systematic study of 108 patients. Ann Neurol (2008) 3.03
Sleep loss and REM sleep loss are hyperalgesic. Sleep (2006) 3.03
Place of chronic insomnia in the course of depressive and anxiety disorders. J Psychiatr Res (2002) 2.99
Missense mutations in the sodium-gated potassium channel gene KCNT1 cause severe autosomal dominant nocturnal frontal lobe epilepsy. Nat Genet (2012) 2.98
Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder. Biol Psychiatry (2006) 2.86
Progression and regression of sleep-disordered breathing with changes in weight: the Sleep Heart Health Study. Arch Intern Med (2005) 2.79
Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans. Am J Hum Genet (2003) 2.71
The association of insomnia with anxiety disorders and depression: exploration of the direction of risk. J Psychiatr Res (2006) 2.60
Sleepiness and sleep in patients with both systolic heart failure and obstructive sleep apnea. Arch Intern Med (2006) 2.53
Modafinil for excessive sleepiness associated with shift-work sleep disorder. N Engl J Med (2005) 2.51
Retracted CD4+ T cell autoimmunity to hypocretin/orexin and cross-reactivity to a 2009 H1N1 influenza A epitope in narcolepsy. Sci Transl Med (2013) 2.51
Prevalence of restless legs syndrome and periodic limb movement disorder in the general population. J Psychosom Res (2002) 2.48
Prevalence and correlates of restless legs syndrome symptoms in the Wisconsin Sleep Cohort. Sleep Med (2006) 2.45
Nocturnal eating: sleep-related eating disorder or night eating syndrome? A videopolysomnographic study. Sleep (2006) 2.35
Correlates of sleep-onset REM periods during the Multiple Sleep Latency Test in community adults. Brain (2006) 2.35
Characterization of sleep in zebrafish and insomnia in hypocretin receptor mutants. PLoS Biol (2007) 2.34
Longitudinal association of sleep-related breathing disorder and depression. Arch Intern Med (2006) 2.30
The role of hypocretins (orexins) in sleep regulation and narcolepsy. Annu Rev Neurosci (2002) 2.28
Genetics of sleep and sleep disorders. Cell (2011) 2.26
New approaches to the study of periodic leg movements during sleep in restless legs syndrome. Sleep (2006) 2.24
Short-term variability of respiration and sleep during unattended nonlaboratory polysomnography--the Sleep Heart Health Study. [corrected]. Sleep (2002) 2.20
Early CPAP use identifies subsequent adherence to CPAP therapy. Sleep (2007) 2.19
Sleep duration and body mass index in a rural population. Arch Intern Med (2006) 2.19
Sleep in lifetime posttraumatic stress disorder: a community-based polysomnographic study. Arch Gen Psychiatry (2004) 2.13
Variant between CPT1B and CHKB associated with susceptibility to narcolepsy. Nat Genet (2008) 2.09
Epidemiology of DSM-IV insomnia in adolescence: lifetime prevalence, chronicity, and an emergent gender difference. Pediatrics (2006) 2.06
Burden of sleep apnea: rationale, design, and major findings of the Wisconsin Sleep Cohort study. WMJ (2009) 2.06
Movement disorders in sleep: guidelines for differentiating epileptic from non-epileptic motor phenomena arising from sleep. Sleep Med Rev (2007) 2.00
Long-term outcome of hematuria home screening for bladder cancer in men. Cancer (2006) 1.95
Correlates of serum C-reactive protein (CRP)--no association with sleep duration or sleep disordered breathing. Sleep (2007) 1.88
The association between obesity and short sleep duration: a population-based study. J Clin Sleep Med (2005) 1.87
The pediatric daytime sleepiness scale (PDSS): sleep habits and school outcomes in middle-school children. Sleep (2003) 1.86
DQB1*0602 predicts interindividual differences in physiologic sleep, sleepiness, and fatigue. Neurology (2010) 1.86
Vulnerability to stress-related sleep disturbance and hyperarousal. Sleep (2004) 1.84
Diagnosis, disease course, and management of patients with Kleine-Levin syndrome. Lancet Neurol (2012) 1.83
Orexin receptor antagonism for treatment of insomnia: a randomized clinical trial of suvorexant. Neurology (2012) 1.83
Insomnia and the performance of US workers: results from the America insomnia survey. Sleep (2011) 1.77
Sleep, sleepiness, sleep disorders and alcohol use and abuse. Sleep Med Rev (2001) 1.75
Categorical versus dimensional approaches to diagnosis: methodological challenges. J Psychiatr Res (2004) 1.74
Epidemiology of restless legs syndrome: a synthesis of the literature. Sleep Med Rev (2011) 1.74
Prevalence, demographics, and psychological associations of sleep disruption in patients with cancer: University of Rochester Cancer Center-Community Clinical Oncology Program. J Clin Oncol (2009) 1.73
Using difficulty resuming sleep to define nocturnal awakenings. Sleep Med (2010) 1.73
Nightly treatment of primary insomnia with eszopiclone for six months: effect on sleep, quality of life, and work limitations. Sleep (2007) 1.72
Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials. Lancet (2008) 1.72
The narcoleptic borderland: a multimodal diagnostic approach including cerebrospinal fluid levels of hypocretin-1 (orexin A). Sleep Med (2003) 1.72
Association of restless legs syndrome with nocturnal eating: a case-control study. Mov Disord (2009) 1.70
Obstructive sleep apnea during REM sleep and hypertension. results of the Wisconsin Sleep Cohort. Am J Respir Crit Care Med (2014) 1.68
Ran GTPase regulates hemocytic phagocytosis of shrimp by interaction with myosin. J Proteome Res (2009) 1.68
A link between short sleep and obesity: building the evidence for causation. Sleep (2005) 1.67
Age-dependent associations between sleep-disordered breathing and hypertension: importance of discriminating between systolic/diastolic hypertension and isolated systolic hypertension in the Sleep Heart Health Study. Circulation (2005) 1.67
Neuroanatomy of fragile X syndrome is associated with aberrant behavior and the fragile X mental retardation protein (FMRP). Ann Neurol (2008) 1.66
Common variants in P2RY11 are associated with narcolepsy. Nat Genet (2010) 1.65
Clinical and therapeutic aspects of childhood narcolepsy-cataplexy: a retrospective study of 51 children. Sleep (2010) 1.64
Circadian and homeostatic regulation of hypocretin in a primate model: implications for the consolidation of wakefulness. J Neurosci (2003) 1.64
Association of psychiatric disorders and sleep apnea in a large cohort. Sleep (2005) 1.62
Hormone replacement therapy and sleep-disordered breathing. Am J Respir Crit Care Med (2003) 1.61
Late-life anxiety and cognitive impairment: a review. Am J Geriatr Psychiatry (2008) 1.61
Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation. Liver Transpl (2009) 1.60
Clinical aspects of narcolepsy-cataplexy across ethnic groups. Sleep (2002) 1.59